{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:25:58Z","timestamp":1768911958198,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100006075","name":"Greta och Johan Kock Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-015-0907-8","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T11:16:28Z","timestamp":1452597388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Elevated levels of faecal calprotectin in primary Sj\u00f6gren\u2019s syndrome is common and associated with concomitant organic gastrointestinal disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Kristofer","family":"Andr\u00e9asson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodil","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mandl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,12]]},"reference":[{"issue":"6","key":"907_CR1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"907_CR2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al. EULAR Sj\u00f6gren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2010;69(6):1103\u20139. A published erratum appears in Ann Rheum Dis. 2011;70(5):880.","journal-title":"Ann Rheum Dis"},{"key":"907_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/15027732.1986.12461401","volume":"61","author":"EB Tsianos","year":"1986","unstructured":"Tsianos EB, Vasakos S, Drosos AA, Malamou-Mitsi VD, Moutsopoulos HM. The gastrointestinal involvement in primary Sj\u00f6gren\u2019s syndrome. Scand J Rheumatol Suppl. 1986;61:151\u20135.","journal-title":"Scand J Rheumatol Suppl"},{"issue":"1","key":"907_CR4","first-page":"21","volume":"11","author":"PA Ostuni","year":"1993","unstructured":"Ostuni PA, Germana B, Di Mario F, Rugge M, Plebani M, De Zambiasi P, et al. Gastric involvement in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 1993;11(1):21\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"907_CR5","first-page":"9","volume":"90","author":"SH Sheikh","year":"1995","unstructured":"Sheikh SH, Shaw-Stiffel TA. The gastrointestinal manifestations of Sj\u00f6gren\u2019s syndrome. Am J Gastroenterol. 1995;90(1):9\u201314.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"907_CR6","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3899\/jrheum.100280","volume":"37","author":"O Hammar","year":"2010","unstructured":"Hammar O, Ohlsson B, Wollmer P, Mandl T. Impaired gastric emptying in primary Sj\u00f6gren\u2019s syndrome. J Rheumatol. 2010;37(11):2313\u20138.","journal-title":"J Rheumatol"},{"issue":"7","key":"907_CR7","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/j.1572-0241.1999.01146.x","volume":"94","author":"A Barton","year":"1999","unstructured":"Barton A, Pal B, Whorwell PJ, Marshall D. Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome. Am J Gastroenterol. 1999;94(7):1898\u2013901.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"907_CR8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2222.2008.02983.x","volume":"38","author":"M Lid\u00e9n","year":"2008","unstructured":"Lid\u00e9n M, Kristj\u00e1nsson G, Valtysdottir S, Venge P, H\u00e4llgren R. Cow\u2019s milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Exp Allergy. 2008;38(6):929\u201335.","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"907_CR9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/03009740802709069","volume":"38","author":"B Ohlsson","year":"2009","unstructured":"Ohlsson B, Scheja A, Janciauskiene S, Mandl T. Functional bowel symptoms and GnRH antibodies: common findings in patients with primary Sj\u00f6gren\u2019s syndrome but not in systemic sclerosis. Scand J Rheumatol. 2009;38(5):391\u20133.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"907_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01318111","volume":"31","author":"G Kjell\u00e9n","year":"1986","unstructured":"Kjell\u00e9n G, Fransson SG, Lindstr\u00f6m F, S\u00f6kjer H, Tibbling L. Esophageal function, radiography, and dysphagia in Sj\u00f6gren\u2019s syndrome. Dig Dis Sci. 1986;31(3):225\u20139.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"907_CR11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/art.1780280406","volume":"28","author":"CP Maury","year":"1985","unstructured":"Maury CP, T\u00f6rnroth T, Teppo AM. Atrophic gastritis in Sj\u00f6gren\u2019s syndrome: morphologic, biochemical, and immunologic findings. Arthritis Rheum. 1985;28(4):388\u201394.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"907_CR12","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.1999.01011.x","volume":"94","author":"S Iltanen","year":"1999","unstructured":"Iltanen S, Collin P, Korpela M, Holm K, Partanen J, Polvi A, et al. Celiac disease and markers of celiac disease latency in patients with primary Sj\u00f6gren\u2019s syndrome. Am J Gastroenterol. 1999;94(4):1042\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"907_CR13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/rhe.31.3.140.145","volume":"31","author":"\u00d8 Palm","year":"2002","unstructured":"Palm \u00d8, Moum B, Gran JT. Estimation of Sj\u00f6gren\u2019s syndrome among IBD patients: a six year post-diagnostic prevalence study. Scand J Rheumatol. 2002;31(3):140\u20135.","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"907_CR14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2013-203305","volume":"73","author":"Y Liang","year":"2014","unstructured":"Liang Y, Yang Z, Qin B, Zhong R. Primary Sj\u00f6gren\u2019s syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis. 2014;73(6):1151\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"907_CR15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/00365529209011186","volume":"27","author":"AG R\u00f8seth","year":"1992","unstructured":"R\u00f8seth AG, Fagerhol MK, Aadland E, Schj\u00f8nsby H. Assessment of the neutrophil dominating protein calprotectin in feces: a methodologic study. Scand J Gastroenterol. 1992;27(9):793\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"907_CR16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00365529950172835","volume":"34","author":"AG R\u00f8seth","year":"1999","unstructured":"R\u00f8seth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999;34(1):50\u20134.","journal-title":"Scand J Gastroenterol"},{"key":"907_CR17","doi-asserted-by":"crossref","unstructured":"Waugh N, Cummins E, Royle P, Kandala NB, Shyangdan D, Arasaradnam R, et al. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess. 2013;17(55). doi: 10.3310\/hta17550 .","DOI":"10.3310\/hta17550"},{"key":"907_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-230X-12-5","volume":"12","author":"M Manz","year":"2012","unstructured":"Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, Rossi L, et al. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterol. 2012;12:5.","journal-title":"BMC Gastroenterol"},{"key":"907_CR19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-230X-14-57","volume":"14","author":"E Burri","year":"2014","unstructured":"Burri E, Manz M, Schroeder P, Froehlich F, Rossi L, Beglinger C, et al. Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness. BMC Gastroenterol. 2014;14:57.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"907_CR20","first-page":"24","volume":"47","author":"GL Norman","year":"2015","unstructured":"Norman GL. Fecal calprotectin: an inflammatory biomarker with emerging importance in the clinical laboratory. MLO Med Lab Obs. 2015;47(5):24\u20136.","journal-title":"MLO Med Lab Obs"},{"key":"907_CR21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cca.2012.11.008","volume":"416","author":"E Burri","year":"2013","unstructured":"Burri E, Manz M, Rothen C, Rossi L, Beglinger C, Lehmann FS. Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort. Clin Chim Acta. 2013;416:41\u20137.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"907_CR22","first-page":"237","volume":"15","author":"DA Drossman","year":"2006","unstructured":"Drossman DA, Dumitrascu DL. Rome III: new standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis. 2006;15(3):237\u201341.","journal-title":"J Gastrointestin Liver Dis"},{"key":"907_CR23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-230X-11-122","volume":"11","author":"M Bengtsson","year":"2011","unstructured":"Bengtsson M, Hammar O, Mandl T, Ohlsson B. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2011;11:122.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"907_CR24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al. EULAR Sj\u00f6gren\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2011;70(6):968\u201372.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"907_CR25","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar4475","volume":"16","author":"K Andr\u00e9asson","year":"2014","unstructured":"Andr\u00e9asson K, Saxne T, Scheja A, Bartosik I, Mandl T, Hesselstrand R. Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sj\u00f6gren\u2019s syndrome and rheumatoid arthritis. Arthritis Res Ther. 2014;16(1):R46.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"907_CR26","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1177\/0300060513488499","volume":"41","author":"S Wang","year":"2013","unstructured":"Wang S, Wang Z, Shi H, Heng L, Juan W, Yuan B, et al. Faecal calprotectin concentrations in gastrointestinal diseases. J Int Med Res. 2013;41(4):1357\u201361.","journal-title":"J Int Med Res"},{"issue":"5","key":"907_CR27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11695-013-1166-x","volume":"24","author":"KA Carswell","year":"2014","unstructured":"Carswell KA, Vincent RP, Belgaumkar AP, Sherwood RA, Amiel SA, Patel AG, et al. The effect of bariatric surgery on intestinal absorption and transit time. Obes Surg. 2014;24(5):796\u2013805.","journal-title":"Obes Surg"},{"issue":"5","key":"907_CR28","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/j.gastro.2005.03.020","volume":"128","author":"L Maiden","year":"2005","unstructured":"Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology. 2005;128(5):1172\u20138.","journal-title":"Gastroenterology"},{"issue":"3","key":"907_CR29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/03009749409103041","volume":"23","author":"JG Brun","year":"1994","unstructured":"Brun JG, Cuida M, Jacobsen H, Kloster R, Johannesen AC, H\u00f8yeraal HM, et al. Sj\u00f6gren\u2019s syndrome in inflammatory rheumatic diseases: analysis of the leukocyte protein calprotectin in plasma and saliva. Scand J Rheumatol. 1994;23(3):114\u20138.","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"907_CR30","doi-asserted-by":"crossref","first-page":"e004558","DOI":"10.1136\/bmjopen-2013-004558","volume":"4","author":"C Prell","year":"2014","unstructured":"Prell C, Nagel D, Freudenberg F, Schwarzer A, Koletzko S. Comparison of three tests for faecal calprotectin in children and young adults: a retrospective monocentric study. BMJ Open. 2014;4(5):e004558.","journal-title":"BMJ Open"},{"issue":"1","key":"907_CR31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/flgastro-2013-100420","volume":"6","author":"A Dhaliwal","year":"2015","unstructured":"Dhaliwal A, Zeino Z, Tomkins C, Cheung M, Nwokolo C, Smith S, et al. Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply? Frontline Gastroenterol. 2015;6(1):14\u20139.","journal-title":"Frontline Gastroenterol"},{"issue":"5","key":"907_CR32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00296-003-0360-x","volume":"24","author":"P Szodaray","year":"2004","unstructured":"Szodaray P, Barta Z, Lakos G, Szak\u00e1ll S, Zeher M. Coeliac disease in Sj\u00f6gren\u2019s syndrome\u2014a study of 111 Hungarian patients. Rheumatol Int. 2004;24(5):278\u201382.","journal-title":"Rheumatol Int"},{"issue":"8","key":"907_CR33","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/00365520601173632","volume":"42","author":"M Montalto","year":"2007","unstructured":"Montalto M, Santoro L, Curigliano V, D\u2019Onofrio F, Cammarota G, Panunzi S, et al. Faecal calprotectin concentrations in untreated coeliac patients. Scand J Gastroenterol. 2007;42(8):957\u201361.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"907_CR34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/00365521.2011.648953","volume":"47","author":"E Klingberg","year":"2012","unstructured":"Klingberg E, Carlsten H, Hilme E, Hedberg M, Forsblad-d\u2019Elia H. Calprotectin in ankylosing spondylitis \u2013 frequently elevated in feces, but normal in serum. Scand J Gastroenterol. 2012;47(4):435\u201344.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"907_CR35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.autrev.2015.01.018","volume":"14","author":"I Marie","year":"2015","unstructured":"Marie I, Leroi AM, Menard JF, Levesque H, Quillard M, Ducrotte P. Fecal calprotectin in systemic sclerosis and review of the literature. Autoimmun Rev. 2015;14(6):547\u201354.","journal-title":"Autoimmun Rev"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0907-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T03:25:48Z","timestamp":1748748348000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.com\/content\/18\/1\/9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0907-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,12]]},"article-number":"9"}}